Información de la revista
Original article
Acceso a texto completo
The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis
Seguridad y eficacia de tolvaptan en el tratamiento de los pacientes con enfermedad renal poliquística autosómica dominante: Revisión sistemática y metaanálisis
Xuanwei Lia, Wenlai Lia, Yue Lib, Chuanjiang Dongc, Ping Zhua,
Autor para correspondencia
1793224966@qq.com

Corresponding author.
a Division of Nephrology, The First College of Clinical Medical Science, Three Gorges University, Yichang, Hubei, China
b Division of Endocrinology, The Renhe Hospital of Three Gorges University, Yichang, Hubei, China
c Division of Urinary Surgery, The First College of Clinical Medical Science, Three Gorges University , Yichang, Hubei, China

Artículo

This article is available in English

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis

Xuanwei Li, Wenlai Li, Yue Li, Chuanjiang Dong, Ping Zhu
10.1016/j.nefroe.2023.04.002
Nefrologia (English Version). 2023;43:731-41
Idiomas
Nefrología
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?